Trauma: Clinical Trials

30 trials for Trauma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 6 unknown, 4 terminated, 2 not yet recruiting. 30 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 330Completed 14, Unknown 6, Terminated 4, Not yet recruiting 2, Recruiting 2, Withdrawn 2
Phase 24Completed 2, Not yet recruiting 1, Unknown 1

Follow Trauma: new trials by email Literature Review of Trauma trials Research Report on Trauma

Trials (filtered) newest first · largest first

All 30 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Calcium Administration in Life-saving Management During Massive Hemorrhage
calcium gluconate, Control: Placebo - Massive Hemorrhage, Trauma
Phase 2 / Phase 3Not yet recruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's812025-05-012025-02-11
Empiric Calcium in Massive Transfusion
Calcium Gluconate - Hemorrhage, Trauma
Phase 3WithdrawnUniversity of California, Irvine2025-01-012026-03-30
Frozen Platelets in the Treatmentof Traumatic or Vascular Bleeding
Deep-frozen platelets - Trauma, Bleeding
Phase 3UnknownAlrijne Ziekenhuis Leiderdorp1582023-06-012023-02-01
Whole Blood in Trauma Patients With Hemorrhagic Shock
Transfusion of blood products - Trauma, Trauma Injury
Phase 3RecruitingFundacion Clinica Valle del Lili2202023-01-142025-02-27
Fibrinogen Early In Severe Trauma StudY II
Fibrinogen Concentrate, Cryoprecipitate - Trauma, Haemorrhagic Shock
Phase 3CompletedAustralian and New Zealand Intensive Care Research Centre9002022-11-212026-09-09
Evaluation of a Transfusion Therapy Using Whole Blood in the Management of Coagulopathy in Patients With Acute Traumatic Hemorrhage
Whole blood transfusion, Fractionated blood products transfusion - Trauma, Acute Hemorrhage
Phase 3CompletedDirection Centrale du Service de Santé des Armées2002021-12-042026-01-26
Restarting Anticoagulation After Traumatic Intracranial Hemorrhage
Anticoagulants - Hemorrhage, Intracranial Hemorrhages
Phase 3Not yet recruitingUniversity of Texas at Austin11002021-10-012021-05-19
ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
Epoetin Alfa 40000 UNT/ML, Sodium Chloride 0.9% - Trauma, Traumatic Injury
Phase 3RecruitingAustralian and New Zealand Intensive Care Research Centre25002020-11-092025-07-16
Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study
Aveed 750 MG in 3 ML IM Injection, Normal Saline 3 ML IM Injection - Muscle Atrophy, Surgery
Phase 2 / Phase 3UnknownThe Stone Research Foundation for Sports Medicine and Arthritis152020-05-082021-08-31
Humacyte Acellular Tissue Engineered Vessel (ATEV) in Patients With Vascular Trauma
Acellular Tissue Engineered Vessel (ATEV) - Trauma, Vascular System Injury
Phase 2 / Phase 3CompletedHumacyte, Inc.722018-09-012026-07-29
Efficacy of Lidocaine Patch in Acute Musculoskeletal Pain in the Emergency Department
Ibuprofen, Lidocaine Patch 4% - Acute Musculoskeletal Disease, Sprains
Phase 3CompletedEast Carolina University232018-06-232024-03-25
Polymyxin B Monotherapy vs Combination Therapy in Critically Ill Patients With Multi-drug Resistant Pathogens
Polymyxin B - Trauma, Resistant Infection
Phase 3UnknownUniversity of Puerto Rico402017-05-252019-02-08
PREVENTion of Clot in Orthopaedic Trauma
Acetylsalicylic acid, Low Molecular Weight Heparin (LMWH) - Blood Clot, Trauma
Phase 3CompletedMajor Extremity Trauma Research Consortium124242017-04-242024-05-14
Supplemental Enteral Protein in Critical Illness
Protein supplementation, Standard enteral nutrition - Nutrition Disorder, Trauma
Phase 3CompletedUniversity of Washington5002016-11-012024-06-05
Helping Children With Trauma
Trauma Systems Therapy (TST), Treatment as Usual (TAU) - Trauma, Post-Traumatic Stress Disorder
Phase 3TerminatedNYU Langone Health142016-02-012017-03-31
Dexmedetomidine Versus Propofol for Prolonged Sedation in Poly Traumatized Mechanically Ventilated Patients
Dexmedetomidine, Propofol - Trauma
Phase 2 / Phase 3CompletedAssiut University602015-11-012016-08-23
Comparative Study of Loxoprofen Sodium Transdermal Patch and Loxonin® Tablets for the Treatment of Acute Trauma
Transdermal Patch, Loxoprofen sodium, Placebo (for loxoprofen sodium) - Trauma, Pain
Phase 3CompletedDaiichi Sankyo Brasil Farmacêutica LTDA2422015-10-012017-02-14
Freeze-dried Plasma in the Initial Management of Coagulopathy in Trauma Patients
Freezed-dried plasma, Fresh-frozen plasma - Trauma, Coagulopathy
Phase 3CompletedUniversity Hospital, Lille422013-07-092026-04-22
Nutritional Requirement for the Severe Trauma Patients
high caloric nutritional supplement, low caloric nutritional supplement - Trauma
Phase 3UnknownAsan Medical Center612012-11-012013-01-04
Pragmatic, Randomized Optimal Platelet and Plasma Ratios
1:1:1 Blood Transfusion Ratio, 1:1:2 Blood Transfusion Ratio - Trauma
Phase 3CompletedThe University of Texas Health Science Center, Houston6802012-08-012019-02-08

Showing 20 of 30. Sign in to see all of them.

Narrower conditions

Wounds and Injuries (30)  ·  Hemorrhage (5)  ·  Hemostatic Disorders (4)  ·  Critical Illness (3)  ·  Multiple Trauma (3)  ·  Shock, Hemorrhagic (3)  ·  Brain Injuries, Traumatic (2)  ·  Hypocalcemia (2)  ·  Inflammation (2)  ·  Muscular Atrophy (2)  ·  Shock (2)  ·  Sprains and Strains (2)  ·  Stress Disorders, Post-Traumatic (2)  ·  Thrombosis (2)  ·  Accidental Injuries (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (16)  ·  Pathologic Processes (12)  ·  Cardiovascular Diseases (10)  ·  Vascular Diseases (10)  ·  Nervous System Diseases (7)  ·  Neurologic Manifestations (5)  ·  Signs and Symptoms (5)  ·  Brain Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Disease Attributes (4)  ·  Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Hemorrhagic Disorders (4)  ·  Infections (4)  ·  Nutritional and Metabolic Diseases (4)

Interventions

Sodium Chloride (4)  ·  Calcium (2)  ·  Calcium Gluconate (2)  ·  Anticoagulants (1)  ·  Ascorbic Acid (1)  ·  Aspirin (1)  ·  Blood Transfusion (1)  ·  Cilastatin, Imipenem Drug Combination (1)  ·  Complement C1 Inhibitor Protein (1)  ·  Dexmedetomidine (1)  ·  Docosahexaenoic Acids (1)  ·  Enoxaparin (1)  ·  Epoetin Alfa (1)  ·  Estradiol (1)  ·  Exchange Transfusion, Whole Blood (1)

Sponsors

Australian and New Zealand Intensive Care Research Centre (2)  ·  Novo Nordisk A/S (2)  ·  Alrijne Ziekenhuis Leiderdorp (1)  ·  Asan Medical Center (1)  ·  Assiut University (1)  ·  Centre Hospitalier Universitaire Vaudois (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Daiichi Sankyo Brasil Farmacêutica LTDA (1)  ·  Direction Centrale du Service de Santé des Armées (1)  ·  East Carolina University (1)  ·  Fundacion Clinica Valle del Lili (1)  ·  Humacyte, Inc. (1)  ·  Japan Science and Technology Agency (1)  ·  Laboratorio Brasileiro de Biologia (1)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)

Countries

United States (11)  ·  France (4)  ·  Brazil (3)  ·  Germany (3)  ·  Switzerland (3)  ·  Australia (2)  ·  Canada (2)  ·  Netherlands (2)  ·  New Zealand (2)  ·  United Kingdom (2)  ·  Belgium (1)  ·  Colombia (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Egypt (1)

Top investigators

Abel Pereira Junior, investigator (1)  ·  Alberto F Garcia, MD MSc (1)  ·  Associate Professor Craig French (1)  ·  Bartholomew Tortella, MD (1)  ·  Femke Noorman, PhD (1)  ·  Glenn Saxe, MD (1)  ·  Grant O'Keefe, MD (1)  ·  Hala S Abdel-Ghaffar, MD (1)  ·  Jakob Stensballe, MD (1)

Results publications

PMID 10319217, PMID 10376632, PMID 10623981, PMID 15269195, PMID 15851777, PMID 17121631, PMID 17349504, PMID 17785483, PMID 18199038, PMID 18444865, PMID 18625681, PMID 18687132, PMID 19374579, PMID 20175247, PMID 21793988, PMID 21988742, PMID 2205779, PMID 22252816, PMID 22752516, PMID 23394211, PMID 23616495, PMID 23697744, PMID 24191943, PMID 24335442, PMID 24514083, PMID 24996573, PMID 25066331, PMID 25430979, PMID 25461655, PMID 25481088, PMID 25647203, PMID 26151924, PMID 26259799, PMID 26335087, PMID 26452709, PMID 27418577, PMID 28731937, PMID 28840147, PMID 28930959, PMID 29274254, PMID 29766088, PMID 30030268, PMID 30447946, PMID 31050809, PMID 31604788, PMID 3344884, PMID 33797501, PMID 3461421, PMID 35141873, PMID 36153539

NIH funding

2005 (1), R01GM127790 (1), U01HL077863 (1)